Press releases

19 April 2008,

New Antibiotic Class proves effective against MRSA
(more >>)

29 March 2007,

Dr Robert Nolan, ex Director of NeuTec Pharma, joins the Phico Therapeutics Board (more >>)

11 January 2007,

Phico Therapeutics raises £1.5 million for clinical trials with its anti-MRSA product (more >>)

19 September 2005,

Phico Therapeutics - successful fundraising (more >>)

12 January 2005,

Phico Therapeutics has expanded.... (more >>)

19 August 2004,

Phico Therapeutics - successful fundraising allows company to develop novel treatment for superbug, MRSA (more >>)

1 August 2002,

Phico Therapeutics - New investment supports development of anti-MRSA technology (more >>)